The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Epigenetic Determinants of Cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic and epigenetic alterations are known to play a key role in silencing of tumor suppressor genes34,35.”
From Gadd45g insufficiency drives the pathogenesis of myeloproliferative neoplasms (2024) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945 · cited 2×
“These latter include not only standard chemotherapies, but also, intriguingly, an exciting new immunotherapy (Brahmer et al. 2012; Topalian et al. 2012), which targets breaking lymphocyte immune tolerance to render these cells immune competent (Wrangle et al. 2013).”
BackgroundVogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Self-citationHuman DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Self-citationA decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Self-citationFigueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766
The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain
Kriaucionis, S., & Heintz, N. (2009) · Science · doi:10.1126/science.1169786 · Cited by 2,700 · cited 2×
“…Gaudet et al. 2003 5-Azacytidine is FDA approved for treatment of myelodysplastic syndrome Discovery of the 5-hydroxymethylcytosine base and the TET1/2/3 enzymes that catalyze this conversion Kaminskas et al. 2005 Kriaucionis and Heintz 2009; Tahiliani et al. 2009 Adapted from You and Jones 2012.”
BackgroundIDH mutation impairs histone demethylation and results in a block to cell differentiation
Lu, C., Ward, P. S., Kapoor, G. S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C. R., Khanin, R., Figueroa, M. E., Melnick, A., et al. (2012) · Nature · doi:10.1038/nature10860 · Cited by 1,985
DNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Turcan, S., Rohle, D., Goenka, A., Walsh, L. A., Fang, F., Yilmaz, E., Campos, C., Fabius, A. W. M., Lu, C., Ward, P. S., et al. (2012) · Nature · doi:10.1038/nature10866 · Cited by 1,974
Multitarget Stool DNA Testing for Colorectal-Cancer Screening
Imperiale, T. F., Ransohoff, D. F., Itzkowitz, S. H., Levin, T. R., Lavin, P., Lidgard, G. P., Ahlquist, D. A., & Berger, B. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311194 · Cited by 1,900 · cited 2×
“The detection of both CpG island DNA methylation and specific mutations is even more promising for detecting colon polyps and/or cancer by assaying stool blood DNA (Hong and Ahuja 2013; Imperiale et al. 2014) and this approach is moving toward clinical practice.”
BackgroundThe NIH Roadmap Epigenomics Mapping Consortium
Bernstein, B. E., Stamatoyannopoulos, J. A., Costello, J. F., Ren, B., Milosavljevic, A., Meissner, A., Kellis, M., Marra, M. A., Beaudet, A. L., Ecker, J. R., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt1010-1045 · Cited by 1,892
Cellular differentiation, cytidine analogs and DNA methylation
Jones, P. A., & Taylor, S. M. (1980) · Cell · doi:10.1016/0092-8674(80)90237-8 · Cited by 1,831
Self-citationFrequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., et al. (2011) · Nature · doi:10.1038/nature10351 · Cited by 1,614
Suppression of inflammation by a synthetic histone mimic
Nicodeme, E., Jeffrey, K. L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.-W., Chandwani, R., Marazzi, I., Wilson, P., Coste, H., et al. (2010) · Nature · doi:10.1038/nature09589 · Cited by 1,563
Induction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499 · cited 3×
“Indeed, deletion or reduction of the maintenance DNA methyltransferase, Dnmt1, results in increased mutation rates, aneuploidies, and tumor induction, a clear indication that DNA hypomethylation plays an active role in increasing chromosomal fragility (Chen et al. 1998; Narayan et al. 1998; Gaudet et al. 2003; Ehrlich…”
BackgroundNew and emerging HDAC inhibitors for cancer treatment
West, A. C., & Johnstone, R. W. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69738 · Cited by 1,404
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Lewis, P. W., Müller, M. M., Koletsky, M. S., Cordero, F., Lin, S., Banaszynski, L. A., Garcia, B. A., Muir, T. W., Becher, O. J., & Allis, C. D. (2013) · Science · doi:10.1126/science.1232245 · Cited by 1,345
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327
Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1950 · Cited by 1,226 · cited 3×
“Thus, these large domains may harbor a much higher than expected percentage of genes that are vulnerable to abnormal CpG island DNA hypermethylation (Ohm et al. 2007; Schlesinger et al. 2007; Widschwendter et al. 2007; Berman et al. 2012).”
BackgroundKiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206 · cited 1×
“In fact, in cell culture (on plastic), normal human mammary epithelial cells require this type of p16 silencing as a prerequisite for the very early steps toward cell transformation (Kiyono et al. 1998; Romanov et al. 2001).”
BackgroundMethylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
Issa, J.-P. J., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., & Baylin, S. B. (1994) · Nature Genetics · doi:10.1038/ng0894-536 · Cited by 1,191
Self-citationXiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., Liu, L., Liu, Y., Yang, C., Xu, Y., et al. (2012) · Genes & Development · doi:10.1101/gad.191056.112 · Cited by 1,188 · cited 1×
“Interestingly, other Krebs cycle control genes, when mutated in certain tumor types, can also result in decreased a-ketoglutarate levels and similar chromatin and DNA methylation abnormalities (Xiao et al. 2012; Mason and Hornick 2013).”
BackgroundEpigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143
Ohm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., et al. (2007) · Nature Genetics · doi:10.1038/ng1972 · Cited by 1,130
Self-citationStem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a
Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., Cheng, T., DePinho, R. A., Sharpless, N. E., & Scadden, D. T. (2006) · Nature · doi:10.1038/nature05159 · Cited by 1,106
TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity
Williams, K., Christensen, J., Pedersen, M. T., Johansen, J. V., Cloos, P. A. C., Rappsilber, J., & Helin, K. (2011) · Nature · doi:10.1038/nature10066 · Cited by 1,021
Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
Easwaran, H., Tsai, H.-C., & Baylin, S. B. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.015 · Cited by 915
Self-citationHistone H2A.Z and DNA methylation are mutually antagonistic chromatin marks
Zilberman, D., Coleman-Derr, D., Ballinger, T., & Henikoff, S. (2008) · Nature · doi:10.1038/nature07324 · Cited by 593
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
Sasaki, M., Knobbe, C. B., Munger, J. C., Lind, E. F., Brenner, D., Brüstle, A., Harris, I. S., Holmes, R., Wakeham, A., Haight, J., et al. (2012) · Nature · doi:10.1038/nature11323 · Cited by 513
p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3
Wales, M. M., Biel, M. A., Deiry, W. E., Nelkin, B. D., Issa, J.-P., Cavenee, W. K., Kuerbitz, S. J., & Baylin, S. B. (1995) · Nature Medicine · doi:10.1038/nm0695-570 · Cited by 421
Self-citationAging and epigenetic drift: a vicious cycle
Issa, J.-P. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69735 · Cited by 419
Epigenetic Resensitization to Platinum in Ovarian Cancer
Matei, D., Fang, F., Shen, C., Schilder, J., Arnold, A., Zeng, Y., Berry, W. A., Huang, T., & Nephew, K. P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3909 · Cited by 390
O'Hagan, H. M., Mohammad, H. P., & Baylin, S. B. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000155 · Cited by 386
Self-citationSasaki, M., Knobbe, C. B., Itsumi, M., Elia, A. J., Harris, I. S., Chio, I. I. C., Cairns, R. A., McCracken, S., Wakeham, A., Haight, J., et al. (2012) · Genes & Development · doi:10.1101/gad.198200.112 · Cited by 296
Fiskus, W., Sharma, S., Shah, B., Portier, B. P., Devaraj, S. G. T., Liu, K., Iyer, S. P., Bearss, D., & Bhalla, K. N. (2014) · Leukemia · doi:10.1038/leu.2014.119 · Cited by 284
Long-Range Chromatin Interactions
Dekker, J., & Misteli, T. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019356 · Cited by 255
Turcan, S., Fabius, A. W. M., Borodovsky, A., Pedraza, A., Brennan, C., Huse, J., Viale, A., Riggins, G. J., & Chan, T. A. (2013) · Oncotarget · doi:10.18632/oncotarget.1412 · Cited by 240
Wu, Y., Strawn, E., Basir, Z., Halverson, G., & Guo, S.-W. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.05.077 · Cited by 193
Research works printed but not linked: 245
- 10.1172/JCI69736 · DOI
- 10.1101/cshperspect.a018739 · DOI
- 10.1101/cshperspect.a019372 · DOI
- 10.1128/MCB.21.19.6470-6483.2001 · DOI
- 10.1016/j.jcis.2009.07.024 · DOI
- 2013, DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases, Sci Transl Med, 5, 169ra110
- 10.1101/cshperspect.a019521 · DOI
- 10.1038/nrclinonc.2013.42 · DOI
- 10.1074/jbc.M104661200 · DOI
- 10.1016/S1535-6108(02)00234-9 · DOI
- 10.1016/j.cell.2006.11.052 · DOI
- 10.1373/clinchem.2009.140244 · DOI
- 10.1158/0008-5472.CAN-07-0065 · DOI
- 10.1101/cshperspect.a018382 · DOI
- 10.1016/j.cell.2010.10.012 · DOI · Paper page
- 1987, Hypermethylation of the 5′ region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies, Blood, 70, 412, 10.1182/blood.V70.2.412.412 · DOI
- 10.1158/0008-5472.CAN-10-3184 · DOI
- 10.1101/cshperspect.a019463 · DOI
- 10.1101/sqb.2005.70.051 · DOI · Paper page
- 10.1038/ng.969 · DOI · Paper page
- 10.1016/j.ccr.2011.06.010 · DOI
- 10.1016/j.ccr.2012.11.006 · DOI
- 10.18632/oncotarget.1408 · DOI
- 10.1016/j.pharmthera.2014.04.004 · DOI
- 10.1126/science.1147939 · DOI
- 10.1038/sj.emboj.7600509 · DOI
- 10.1101/gad.1640908 · DOI
- 10.1056/NEJMoa0706550 · DOI
- 10.1093/jnci/93.9.691 · DOI
- 10.1038/onc.2013.178 · DOI
- 10.1038/5047 · DOI
- 10.1007/978-1-59745-522-0_23 · DOI
- 10.1038/nature11247 · DOI · Paper page
- 10.1016/0006-2952(83)90293-9 · DOI
- 10.1016/j.cell.2013.06.005 · DOI
- 10.1101/gad.217778.113 · DOI · Paper page
- 10.1158/1078-0432.CCR-10-2156 · DOI
- 10.1038/25779 · DOI
- 10.1038/ng1077 · DOI
- 10.1016/j.ccr.2004.08.030 · DOI
- 10.1016/j.cell.2005.08.011 · DOI
- 10.1101/cshperspect.a018747 · DOI
- 10.1126/science.1166261 · DOI
- 10.1158/1535-7163.MCT-05-0172 · DOI
- 10.1093/nar/gks031 · DOI
- 10.1158/2159-8290.CD-13-0117 · DOI
- 10.1016/j.ccr.2011.06.009 · DOI
- 10.1038/77083 · DOI
- 10.1182/blood.V100.8.2957 · DOI
- 10.1016/j.cell.2012.06.013 · DOI · Paper page
- 10.1038/nature10509 · DOI
- 10.1056/NEJMra1112635 · DOI
- 10.1016/j.tcb.2010.08.003 · DOI
- 2010, Genetics of basal cell carcinoma, Australasian J Dermatol, 51, 81, 10.1111/j.1440-0960.2009.00579.x · DOI
- 10.2217/epi.11.105 · DOI · Paper page
- 10.1016/j.cell.2011.08.017 · DOI
- 10.1126/science.1065173 · DOI
- 10.1038/ncb2038 · DOI
- 10.1101/gr.131169.111 · DOI
- 10.1007/978-1-4419-9967-2_2 · DOI
- 10.1093/nar/10.8.2709 · DOI
- 10.1038/nchembio.1107 · DOI
- 10.1038/nrg2005 · DOI
- 10.1056/NEJMra072067 · DOI
- 10.1056/NEJM200011093431901 · DOI
- 10.1093/hmg/10.26.3001 · DOI
- 2001, Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis, Cancer Res, 61, 4689
- 2002, Dependence of histone modifications and gene expression on DNA hypermethylation in cancer, Cancer Res, 62, 7213
- 10.1038/301089a0 · DOI
- 10.1073/pnas.94.13.6770 · DOI
- 10.1016/0092-8674(93)90546-3 · DOI
- 10.1158/1535-7163.MCT-13-0770 · DOI
- 10.1128/MCB.4.10.2098 · DOI
- 1984, Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study, Am Rev Respir Dis, 130, 549
- 10.1038/71750 · DOI
- 10.1093/emboj/20.10.2536 · DOI · Paper page
- 10.1093/nar/gkg332 · DOI
- 10.1073/pnas.0806437105 · DOI
- 10.1097/CCO.0b013e328313699c · DOI
- 10.1016/j.cell.2013.03.002 · DOI
- 2002, A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor, Cancer Res, 62, 3925
- 10.1128/MCB.25.11.4727-4741.2005 · DOI
- 10.1158/0008-5472.CAN-06-0080 · DOI
- 10.1038/79120 · DOI
- 1994, Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis, Cancer Res, 54, 4855
- 10.1101/cshperspect.a019331 · DOI
- 10.1097/PAS.0b013e318212782a · DOI
- 10.1038/ng.907 · DOI
- 10.1158/0008-5472.CAN-08-1957 · DOI
- 10.1038/nature11404 · DOI · Paper page
- 10.1038/ng.865 · DOI
- 10.1038/nbt.1682 · DOI
- 10.1056/NEJMoa043331 · DOI · Paper page
- 10.1056/NEJMra023075 · DOI
- 10.1073/pnas.93.18.9821 · DOI
- 10.1073/pnas.95.12.6870 · DOI
- 10.1101/gr.117523.110 · DOI
- 10.1016/j.ccr.2011.07.003 · DOI
- 10.1016/j.ccr.2005.09.007 · DOI
- 2003, Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia, Cancer Res, 63, 1596
- 10.1101/gr.125872.111 · DOI · Paper page
- 10.1089/gtmb.2012.0478 · DOI
- 10.1136/gutjnl-2012-304219 · DOI
- 10.1182/blood-2003-03-0687 · DOI
- 10.1093/abbs/gmp040 · DOI
- 10.1038/nrg3230 · DOI · Paper page
- 2002, The fundamental role of epigenetic events in cancer, Nat Rev Genet, 3, 415, 10.1038/nrg816 · DOI · Paper page
- 10.1016/j.cell.2007.01.029 · DOI · Paper page
- 10.1038/5947 · DOI
- 10.1038/nrg2651 · DOI
- 10.1126/science.1196333 · DOI
- 10.1158/2159-8290.CD-11-0214 · DOI
- 10.1158/1078-0432.CCR-04-2135 · DOI
- 10.1016/S0304-3835(02)00689-4 · DOI
- 10.1158/0008-5472.CAN-05-2959 · DOI
- 1999, Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies, Blood, 93, 4347, 10.1182/blood.V93.12.4347 · DOI
- 10.1038/nbt.1678 · DOI
- 10.1101/gr.143008.112 · DOI · Paper page
- 10.1111/j.1365-2559.2011.03819.x · DOI
- 10.1038/386761a0 · DOI · Paper page
- 10.1038/35101031 · DOI
- 10.1128/MCB.23.1.206-215.2003 · DOI
- 10.1101/cshperspect.a018630 · DOI
- 10.1038/ng.2443 · DOI
- 10.1073/pnas.0409875102 · DOI · Paper page
- 10.1038/nrc1045 · DOI
- 10.1016/0092-8674(95)90329-1 · DOI
- 10.1016/0006-291X(79)92015-1 · DOI
- 10.1073/pnas.91.24.11733 · DOI
- 2003, Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation, Cancer Res, 63, 6110
- 10.18632/oncotarget.1782 · DOI
- 10.1101/cshperspect.a019133 · DOI
- 10.1038/ng.903 · DOI
- 10.1038/nature09798 · DOI
- 10.1038/ng0195-48 · DOI
- 10.1101/gad.217406.113 · DOI · Paper page
- 10.1101/gad.226753.113 · DOI
- 2000, DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: Clinical results and possible mechanisms of action, Curr Top Microbiol Immunol, 249, 135
- 10.1016/j.stem.2010.11.013 · DOI
- 10.1101/gr.157529.113 · DOI
- 10.1038/35106079 · DOI · Paper page
- 10.1101/cshperspect.a018762 · DOI
- 10.1038/sj.leu.2404050 · DOI
- 10.1038/modpathol.2013.86 · DOI
- 10.1038/onc.2008.499 · DOI
- 10.1158/0008-5472.CAN-08-0700 · DOI
- 10.1093/hmg/ddm021 · DOI
- 10.1038/sj.onc.1205402 · DOI
- 10.1002/(SICI)1097-0215(19980911)77:6<833::AID-IJC6>3.0.CO;2-V · DOI
- 10.1126/science.1101731 · DOI
- 10.1093/nar/29.22.4598 · DOI
- 10.1016/j.trsl.2014.04.001 · DOI
- 10.1038/nature12488 · DOI
- 10.1016/j.ccr.2010.03.017 · DOI · Paper page
- 10.1016/j.ccr.2011.09.012 · DOI
- 10.1101/cshperspect.a018754 · DOI
- 10.1101/sqb.2010.75.014 · DOI
- 10.1016/j.molcel.2010.03.016 · DOI · Paper page
- 2000, Mutation hotspots and DNA methylation, Curr Top Microbiol Immunol, 249, 1
- 10.1101/cshperspect.a019547 · DOI
- 10.1158/2159-8290.CD-12-0076 · DOI
- 10.1200/JCO.2013.50.3102 · DOI
- 10.1158/2159-8290.CD-11-0209 · DOI
- 10.1101/cshperspect.a018663 · DOI
- 10.1371/journal.pone.0023372 · DOI
- 1995, Loss of imprinting in hepatoblastoma, Cancer research, 55, 1836
- 10.1038/362747a0 · DOI
- 10.1200/JCO.2009.24.9094 · DOI
- 10.1002/bies.201300130 · DOI
- 10.1016/j.semcancer.2012.12.001 · DOI
- 10.1038/35010000 · DOI
- 10.1038/416552a · DOI · Paper page
- 2002, Histone deacetylase inhibitors: A new class of potential therapeutic agents for cancer treatment, Clin Cancer Res, 8, 662
- 10.1126/science.1697983 · DOI
- 10.1038/77124 · DOI · Paper page
- 10.1038/35054579 · DOI · Paper page
- 10.1038/ng1773 · DOI
- 10.1177/1947601911417976 · DOI
- 10.1038/77023 · DOI
- 10.4161/cc.5.19.3340 · DOI
- 10.1016/j.ccr.2006.04.020 · DOI
- 1991, Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene, Am J Hum Genet, 48, 880
- 10.1126/science.1108080 · DOI
- 10.1007/s00018-011-0892-2 · DOI
- 10.1038/ncponc0812 · DOI
- 10.1073/pnas.81.22.6993 · DOI
- 10.1101/cshperspect.a018671 · DOI
- 10.1101/gad.590910 · DOI
- 2007, Comparing the DNA hypermethylome with gene mutations in human colorectal cancer, PLoS Genet, 3, 1709
- 10.1101/cshperspect.a018713 · DOI
- 10.1016/j.cell.2010.02.027 · DOI · Paper page
- 10.1016/j.cell.2013.03.008 · DOI
- 10.1212/01.WNL.0000042422.87384.2F · DOI
- 10.1200/JCO.2002.04.117 · DOI
- 10.1002/cmdc.200900301 · DOI
- 10.1073/pnas.1013224108 · DOI · Paper page
- 10.1186/gb-2012-13-10-r84 · DOI · Paper page
- 10.1126/science.145.3632.548 · DOI
- 10.1182/blood-2009-06-227660 · DOI
- 10.1002/pros.20521 · DOI
200 of 245 shown
Cited by
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887
The molecular hallmarks of epigenetic control
Allis, C. D., & Jenuwein, T. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.59 · Cited by 2,809
The emerging role of epigenetic therapeutics in immuno-oncology
Topper, M. J., Vaz, M., Marrone, K. A., Brahmer, J. R., & Baylin, S. B. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0266-5 · Cited by 433
Self-citationEmerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Garg, P., Malhotra, J., Kulkarni, P., Horne, D., Salgia, R., & Singhal, S. S. (2024) · Cancers · doi:10.3390/cancers16132478 · Cited by 339
Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence
Vissers, M. C. M., & Das, A. B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00809 · Cited by 188
Metadata
- Authors
- Baylin, S. B., & Jones, P. A.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-05-18
- Volume
- 8
- Issue
- 9
- Pages
- a019505
- ISSN
- 1943-0264
- Cited by
- 1,226
- References
- 49
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
